Jyothy Labs share news, announcements and annual reports
NSE: JYOTHYLABBSE: 532926Household ProductsSmall Cap
Jyothy Labs Limited · Formerly Jyothy Laboratories · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2007
Last close ₹171.91down ₹3.15 (1.80%)BSE ₹172.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹175.06.
30 Oct: open ₹174.45, high ₹175.10, low ₹171.00
52-week range of traded prices to 30 Oct 2026
₹171.00Low, 30 Oct 2026₹322.75High, 30 Oct 2025
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and buyback. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,313 Cr603rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.23
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.04%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 19.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,85,76453.8% delivered
Jyothy Labs board meetings
112 filed, newest first. Page 2 of 3.
May 2018
16 May · Board meeting
Jan 2018
17 Jan · Board meeting
Nov 2017
7 Nov · Board meeting
Oct 2017
Jul 2017
May 2017
Mar 2017
31 Mar · Board meeting
Jan 2017
Dec 2016
Oct 2016
25 Oct · Board meeting
Aug 2016
Jul 2016
May 2016
23 May · Board meeting
12 May · Board meeting
Inter-alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2016 and to consider and recommend final dividend, if any, on the Equity Shares of the Company for the financial year 2015-16.
Mar 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
Jan 2015
Oct 2014
20 Oct · Board meeting
Inter-alia to consider the Un-Audited Standalone and Consolidated Financial Results of the Company for the 2nd quarter and half year ended September 30, 2014.
Jul 2014
18 Jul · Board meeting
To consider inter-alia the Un-Audited Financial Results of the Company for the 1st Quarter ended June 30, 2014.
May 2014
22 May · Board meeting
Board of Directors of the Company at its meeting held on May 22, 2014 has transacted the following: (1) Approved, subject to approval of shareholders, the constitution of Employee Stock Option Schemes to create, offer and grant Stock Options to CEO & other permanent employees of the Company and matters connected therewith. (2) Approved extension of the tenure of Mr. S. Raghunandan - Whole Time Director and CEO of the Company by two years i.e. from May 23, 2015 to May 22, 2017.16 May · Board meeting
To consider inter-alia the following : (a) Results of the Company for the Financial Year ended March 31, 2014, and (b) Declaration of dividend, if any, for the said financial year.
Jan 2014
28 Jan · Board meeting
Board of Directors of the companys at its meeting held on January 28, 2014 has approved: (1) Re-appointment of Mr. M. P. Ramachandran as Chairman and Managing Director of the Company for a further period of 5 years w.e.f. April 01, 2014 subject to approval of shareholders at the next Annual General Meeting.15 Jan · Board meeting
Inter-alia to consider the Un-Audited Financial Results of the Company for the 3rd Quarter ended December 31, 2013.
Oct 2013
22 Oct · Board meeting
3 Oct · Board meeting
Inter-alia to consider the Un-Audited Financial Results of the Company for the 2nd Quarter ended September 30, 2013.
Jul 2013
May 2013
11 May · Board meeting
To consider inter-alia the following : (a) Results of the Company for the Financial Year ended March 31, 2013, & (b) Declaration of dividend, if any, for the said Financial Year.
Jan 2013
21 Jan · Board meeting
Inter-alia to consider the Un-Audited Financial Results of the Company for the 3rd Quarter ended December 31, 2012.
Oct 2012
15 Oct · Board meeting
Inter-alia to consider the Un-Audited Financial Results of the Company for the 2nd Quarter / Half Year ended September 30, 2012 .
Jul 2012
17 Jul · Board meeting
To consider and take on the unaudited financial results of the company for the first quarter ended June 30, 2012.
Jun 2012
15 Jun · Board meeting
13 Jun · Board meeting
Inter alia, to consider following : (1) The proposal of Amalgamation of Henkel India Limited (HIL), with Jyothy Laboratories Limited (JLL); (2) The Scheme of Amalgamation between HIL and JLL; (3) The Valuation report for the purpose of exchange ratio; (4) The Fairness Opinion; (5) Other matters incidental and connected to the said amalgamation between HIL and JLL.
May 2012
23 May · Board meeting
Board of Directors of the Company at its meeting held on May 23, 2012 has : (1) Appointed Mr. S. Raghunandan as Whole-time Director and Chief Executive Officer of the Company with effect from May 23, 2012. (2) Appointed Mr. Ramkrishnan Lakshminarayanan as Additional Director (Independent Director) of the Company with effect from May 23, 2012.7 May · Board meeting
To consider inter-alia the following : (a) Results of the Company for the Financial Year ended March 31, 2012; and (b) Declaration of dividend, if any, for the said Financial Year.
Jan 2012
23 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 23, 2012, inter alia, appointed Mr. K. Ullas Kamath, Deputy Managing Director as Joint Managing Director of the Company with effect from January 23, 2012.9 Jan · Board meeting
Inter-alia to consider and take on record the Un-Audited Financial Results of the Company for the 3rd Quarter ended December 31, 2011.
Oct 2011
31 Oct · Board meeting
Inter alia to consider the unaudited financial results of the Company for the 2nd quarter and half year ended September 30, 2011 .
Aug 2011
2 Aug · Board meeting
Inter-alia to consider the Un-audited Financial Results of the Company for the 1st Quarter ended June 30, 2011.
May 2011
20 May · Board meeting
To consider inter-alia the following: (a) Results of the Company for the Financial Year ended March 31, 2011; and (b) Declaration of dividend, if any, for the said Financial Year.
Jan 2011
17 Jan · Board meeting
Inter-alia to consider and take on record the Un-Audited Financial Results of the Company for the 3rd Quarter ended December 31, 2010.
Oct 2010
15 Oct · Board meeting
Inter-alia to consider and take on record the Un-audited Financial Results of the Company for the 2nd Quarter / Half year ended September 30, 2010.